1. Therapeutic effects of the PKR inhibitor C16 suppressing tumor proliferation and angiogenesis in hepatocellular carcinoma in vitro and in vivo
   Takao Watanabe et al, 2020, Scientific Reports CrossRef
2. The diagnostic and prognostic implications of PRKRA expression in HBV-related hepatocellular carcinoma
   Yi-Min Hu et al, 2022, Infectious Agents and Cancer CrossRef
3. Decidual T Cells Exhibit a Highly Differentiated Phenotype and Demonstrate Potential Fetal Specificity and a Strong Transcriptional Response to IFN
   Richard M. Powell et al, 2017, The Journal of Immunology CrossRef
4. circFAM120B functions as a tumor suppressor in esophageal squamous cell carcinoma via the miR-661/PPM1L axis and the PKR/p38 MAPK/EMT pathway
   Huan Song et al, 2022, Cell Death & Disease CrossRef
5. Kisspeptin inhibits cancer growth and metastasis via activation of EIF2AK2
   Tae-Hun Kim et al, 2017, Molecular Medicine Reports CrossRef
6. Roles of protein kinase R in cancer: Potential as a therapeutic target
   Takao Watanabe et al, 2018, Cancer Science CrossRef
7. Neutrophil Protein Kinase R Mediates Endothelial Adhesion and Migration by the Promotion of Neutrophil Actin Polymerization
   Reiko Inoue et al, 2022, The Journal of Immunology CrossRef
8. Inflammation‐Induced Long Intergenic Noncoding RNA (LINC00665) Increases Malignancy Through Activating the Double‐Stranded RNA–Activated Protein Kinase/Nuclear Factor Kappa B Pathway in Hepatocellular Carcinoma
   Jie Ding et al, 2020, Hepatology CrossRef